2015
DOI: 10.4238/2015.october.26.7
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Cx43 gene modification on the proliferation and migration of the human lung squamous carcinoma cell line NCI-H226

Abstract: ABSTRACT. In this study, the human lung squamous carcinoma cell line NCI-H226 was transfected with the recombinant plasmid pBudCE4.1_Cx43 to explore the role of the Cx43 gene in cell growth, cell cycle, and tumor migration. pBudCE4.1-Cx43 was transfected into human lung squamous carcinoma NCI-H226 cells using Lipofectamine TM2000. The mRNA and protein expressions of Cx43 in the transfected cells were detected by reverse transcriptase polymerase chain reaction and western blot analysis. The cell-cell communicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Some in vitro studies have suggested a tumour suppressor role for connexins in the lung. Notably, Cx43 gene transfection can inhibit the migration of the human lung squamous carcinoma cell line NCI-H226 [17]. Other work showed that Cx43 may recruit E-cadherin to inhibit the malignant behaviour of lung cancer cells [18].…”
Section: Introductionmentioning
confidence: 99%
“…Some in vitro studies have suggested a tumour suppressor role for connexins in the lung. Notably, Cx43 gene transfection can inhibit the migration of the human lung squamous carcinoma cell line NCI-H226 [17]. Other work showed that Cx43 may recruit E-cadherin to inhibit the malignant behaviour of lung cancer cells [18].…”
Section: Introductionmentioning
confidence: 99%
“…Existing reports have suggested that the pathogenesis and progression of lung carcinoma are related with various genes. For instance, the transfection of Cx43 gene could hinder the cell migration and proliferation of LUSC cell line NCI-H226 [28]. CDK7 suppression has been reported as an available therapeutic strategy in LUSC via regulating SOX2 amplification [29].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the present study used EGFR-negative SqCC cell lines (13,14). NCI-H520 and NCI-H226 cells, which are human lung SqCC cell lines, which were purchased from the Food Industry Research and Development Institute (15,16). These cells were maintained in RPMI-1640 supplemented with 10% FBS and an antibiotic-antimycotic agent containing amphotericin B, penicillin and streptomycin.…”
Section: Methodsmentioning
confidence: 99%